Millde is a technology-driven company specializing in multi-point Raman spectroscopy and high-sensitivity imaging. It provides non-destructive, label-free analysis of cells, tissues, and materials, primarily through contract research services. Serving regenerative medicine, pharmaceutical, food, and materials industries, Millde delivers high-throughput molecular evaluation. The company also develops and commercializes proprietary multi-point Raman systems and cryogenic Raman technologies, supporting applications from research to industrial implementation.
Drug development for neurodegenerative diseases.
A biotech startup developing T-cell and NK-cell therapies derived from low-immunogenicity iPS cells. It aims to provide new treatments for solid tumors and autoimmune diseases, contributing to the treatment of previously difficult-to-treat intractable diseases.
Development of small-molecule therapeutics targeting RNA.
Our key product is Enteral Ventilation (EVA) technology, that supplies liquid oxygen to premature babies with serious respiratory problems through Gut-Mediated Oxygen Delivery. The program is at the clinical trial stage.
